Deep Tech Startups

Zilift developed permanent-magnet, electrically driven artificial lift technologies for oil and gas wells, including the SpeedDrive through-tubing ESP deployment system and the TorqueDrive electric submersible PCP system for rigless production restoration. The company was acquired by Schlumberger (now SLB) in 2021, and its technologies are now part of SLB's artificial lift portfolio.

1 investor

Zing develops hardware detection systems and cloud software for drone airspace identification and compliance. The company offers Remote ID detection devices, broadcast modules for drone compliance, and a platform for airspace awareness and monitoring.

1 investor

Zip Infrastructure develops Zippar, a next-generation autonomous urban ropeway transit system that runs on independent ropes and gondolas to allow curves and branching, marketed to municipalities and companies as a lower-cost alternative to monorails. The Japan-based company promotes the system for reducing traffic congestion and providing accessible transit stations.

1 investor

ZModal builds infrastructure and software for real-time, model-driven biomanufacturing processes. The company serves biotech and pharmaceutical manufacturers seeking to optimize regulated production of biologics and living tissues.

1 investor

ZOECORE is a farming technology product that increases crop profitability for agricultural operations. The company targets farms across North America with a focus on cannabis cultivation.

1 investor

Zuri develops hybrid-electric uncrewed cargo vertical take-off and landing (VTOL) aircraft, with plans to expand toward a certified six-seater passenger variant. The company designs and manufactures aircraft in-house in Prague, targeting commercial cargo deliveries beginning in 2027-2029.

1 investor

Zymofix develops microbial production using solid-state fermentation, cultivating microorganisms on solid substrates in scalable bioreactors. The company combines microbiology, process development, and formulation expertise to support production at larger volumes.

1 investor

Zywie is a therapeutics company developing small-molecule treatments, including pharmacological chaperones and deuterated and halogenated forms of Ambroxol, for metabolic and neurodegenerative Lysosomal Storage Diseases (LSDs). Its drug-development approach targets protein misfolding and impaired protein trafficking within cells.

1 investor

Research institute conducting work in areas such as virtual and augmented reality, computer vision, intelligent systems and robotics, multimedia and social network analysis, networks and communications, and digital transformation. Its activities include European and national research projects (Horizon Europe, Horizon 2020, FP6-FP7) and service provision.

1 investor

RapidAI is a service company that helps deep-tech startups build and test minimum viable products by integrating AI into planning, development, and marketing, using the HADI (Hypothesis-Action-Data-Insight) cycle. It also assists founders with company formation, grant applications to startup funds, and post-launch market analysis.

1 investor

Narnia Labs builds AslanX, a generative and agentic AI platform for manufacturing that automates the repeated design, simulation, and evaluation steps of product development. It generates novel component geometries and predicts their engineering performance in seconds, targeting use cases such as automotive brake parts, wheels, and jet engine brackets.

1 investor

NeoCannBio is a technology spin-off from KIST developing cannabinoid-based pharmaceuticals and producing hemp-derived cannabinoid drug ingredients, including high-purity CBD via microwave processing and GMP production. The company builds a broad cannabinoid library and develops new drugs for patients with rare and intractable diseases in Korea.

1 investor

Novelty Nobility develops antibody and protein therapeutics for clinical applications. The company's leadership team brings expertise in immunization, affinity maturation, and biopharmaceutical development across therapeutic areas including ophthalmology.

1 investor

Novorex is a drug discovery company that combines AI, fragment-based drug discovery (FBDD), and biophysical validation (SPR, NMR, X-ray crystallography, and wet-lab assays) to develop novel small-molecule therapeutics. It operates in-house CNS and inflammation pipelines with R&D labs in Pangyo, Central, and Jeongeup.

1 investor

NeuroVenti is a biotech company developing neuroprotective and therapeutic agents for neuronal and central nervous system disorders, including a drug candidate (NV01-A02) for autism spectrum disorder currently in domestic Phase 2 clinical trials. It also offers preclinical CDRO services such as candidate discovery, preclinical research consulting, and efficacy and safety evaluation.

1 investor

Deediim develops machine vision sensors for surface inspection, using free-illumination and surface-property-imaging technology to detect defects. The system is aimed at industrial quality inspection and manufacturing applications.

1 investor

DeepFusion AI develops multi-modal sensor fusion software for autonomous perception, centered on 4D imaging radar combined with cameras and LiDAR for real-time object detection and tracking in all weather conditions. It serves autonomous mobility and maritime operations, including automotive ADAS, unmanned surface and ground vehicles, autonomous mobile robots, and wave detection.

1 investor

LigaChemBio is a biotechnology company focused on drug development, particularly in ADC (antibody-drug conjugate) and small molecule therapeutics. The company develops and partners on therapeutic pipelines for pharmaceutical applications.

1 investor

McScience manufactures test systems and scientific measurement equipment for research and development across OLED, solar cells, batteries, and flexible electronics. The company supplies to academic institutions and industrial companies in over 100 countries.

1 investor

Cellebrain is a biotech company developing stem cell-based gene therapies for intractable diseases that currently lack pharmacological treatments. It focuses on gene-cell therapies aimed at improving the quality of life for patients with cancer and chronic diseases.

1 investor

Arion Flight develops long-range wireless power transmission technology based on millimeter-wave beamforming and RF ranging, enabling efficient energy transfer to small unmanned aircraft systems (sUAS) and other applications. The company provides end-to-end solutions including custom ASICs, transmitter/receiver modules, and command-control-communication systems for sustained ISR operations.

1 investor

RX is a small modular reactor (SMR) startup founded by KAERI engineers, providing full-cycle nuclear engineering across reactor core component design, analysis, testing, and licensing under a fabless model. It also develops nuclear-specialized agentic AI to automate design and regulatory licensing document preparation, serving markets such as AI data center power demand and national SMR programs.

1 investor

SDT Inc. is a Korean quantum technology company working across quantum computing, quantum cloud, quantum communication, and quantum sensing, including development of a full-stack quantum computer and quantum-AI hybrid computing systems. It serves industrial and public-sector customers and provides quantum precision measurement and control equipment, cryogenic hardware, and cloud-based quantum computing services.

1 investor

SN Display is a startup developing light-emitting perovskite nanocrystals and related optoelectronic devices for display applications, based on patented materials technology. It holds a portfolio of over 45 patents covering perovskite materials and their device applications.

1 investor